The Oncology Institute, Inc. Earnings
The next earnings date for The Oncology Institute, Inc. has not yet been scheduled.
Analyst Estimates of The Oncology Institute, Inc. Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
The Oncology Institute, Inc. Earnings: Historical
| 11/05/2026 | After Market | $-0.13 | -85.71% |
| 08/06/2026 | After Market | $-0.08 | -14.29% |
| 05/08/2026 | --- | $-0.02 | 77.14% |
| 03/13/2026 | --- | $-0.06 | 33.33% |
| 11/14/2025 | --- | $-0.14 | -23.57% |
| 08/14/2025 | --- | $-0.15 | -25.00% |
| 05/15/2025 | --- | $-0.21 | --- |
| 03/24/2025 | --- | $-0.14 | --- |
| 11/14/2024 | --- | $-0.18 | --- |
| 08/14/2024 | --- | $-0.17 | --- |
More About The Oncology Institute, Inc.
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.
“The Oncology Institute, Inc. Earnings” Can Refer to the The Oncology Institute, Inc. Earnings Date
Some people say “The Oncology Institute, Inc. earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my The Oncology Institute, Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning The Oncology Institute, Inc. Stock on the Earnings Date
If you own The Oncology Institute, Inc. stock (STLN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for The Oncology Institute, Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading The Oncology Institute, Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More The Oncology Institute, Inc. Earnings
You can contact us any time if you would like to ask questions about The Oncology Institute, Inc. earnings or anything else related to the stock market.